OFFICIAL PUBLICATION OF THE UTAH ACADEMY OF FAMILY PHYSICIANS

June 6, 2024

Prognosis Negative: FDA Approves First Opioid/Benzodiazepine Combo Pill for Life Pain Disorder

Washington, D.C. — In an unprecedented move, the U.S. Food and Drug Administration (FDA) has approved a combination pill that includes both an opioid and benzodiazepine, called Chilaxen, to treat Life Pain Disorder (LPD).

Prognosis Negative: FDA Approves First Opioid/Benzodiazepine Combo Pill for Life Pain Disorder Read More »